Literature DB >> 27543453

Feasibility and efficacy of oral rabies vaccine SAG2 in endangered Ethiopian wolves.

Claudio Sillero-Zubiri1, Jorgelina Marino2, Christopher H Gordon3, Eric Bedin4, Alo Hussein5, Fekede Regassa6, Ashley Banyard7, Anthony R Fooks8.   

Abstract

Diseases are a major cause of population declines in endangered populations of several canid species. Parenteral vaccination efforts to protect Ethiopian wolves (Canis simensis) from rabies have targeted the domestic dog reservoir, or the wolves themselves in response to confirmed outbreaks. Oral vaccination offers a more cost-efficient, safe and proactive approach to protect Ethiopian wolves and other threatened canids from rabies. Field trials of the oral vaccine Rabigen® SAG2Dog were undertaken in the Bale Mountains of southeastern Ethiopia. Four different bait types and three delivery methods were tested in twelve Ethiopian wolf packs, and the oral vaccine (using the preferred bait) was trialled in three packs. Vaccine uptake and immunization rates were measured through direct observations and in live-trapped animals through the assessment of biomarker levels and serological status. Commercial baits were never taken by wolves; goat meat baits had the highest uptake, compared to rodent and intestine baits. Targeted delivery from horseback and nocturnal delivery within a pack's territory performed favourably compared to random bait distribution. Bait uptake by non-target species was lowest during the nocturnal blind distribution. Of 21 wolves trapped after vaccination, 14 were positive for the biomarker iophenoxic acid (i.e. ingested the bait and most likely pierced the sachet with the vaccine). Of these, 86% (n=12/14) had levels considered sufficient to provide protective immunity to wildlife (⩾0.20IU/ml), and 50% (n=7/14) demonstrated antibody titres above the universally recognised threshold (⩾0.5IU/ml) -the baseline average was 0.09IU/ml (n=12 wolves). All but one of the wolves vaccinated in 2014 were alive 14months later. Our trials confirm the potential for SAG2, delivered in a goat meat bait, to effectively protect Ethiopian wolves against rabies, supporting the initiative for a more efficient and proactive approach to manage and eventually eliminate rabies in Ethiopian wolf populations. Crown
Copyright © 2016. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bait; Biomarker; Sero-conversion; Vaccine; Wildlife rabies

Mesh:

Substances:

Year:  2016        PMID: 27543453     DOI: 10.1016/j.vaccine.2016.08.021

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Evaluation of immune responses in dogs to oral rabies vaccine under field conditions.

Authors:  Todd G Smith; Max Millien; Ad Vos; Franso A Fracciterne; Kelly Crowdis; Cornelius Chirodea; Alexandra Medley; Richard Chipman; Yunlong Qin; Jesse Blanton; Ryan Wallace
Journal:  Vaccine       Date:  2017-10-17       Impact factor: 3.641

2.  Vaccines for Conservation: Plague, Prairie Dogs & Black-Footed Ferrets as a Case Study.

Authors:  Daniel J Salkeld
Journal:  Ecohealth       Date:  2017-09-06       Impact factor: 4.464

3.  Rabies and Distemper Outbreaks in Smallest Ethiopian Wolf Population.

Authors:  Jorgelina Marino; Claudio Sillero-Zubiri; Asefa Deressa; Eric Bedin; Alemayehu Bitewa; Fekadu Lema; Gebeyehu Rskay; Ashley Banyard; Anthony R Fooks
Journal:  Emerg Infect Dis       Date:  2017-12       Impact factor: 6.883

4.  The Final (Oral Ebola) Vaccine Trial on Captive Chimpanzees?

Authors:  Peter D Walsh; Drishya Kurup; Dana L Hasselschwert; Christoph Wirblich; Jason E Goetzmann; Matthias J Schnell
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

5.  Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild Release.

Authors:  Ruth Pye; Amanda Patchett; Elspeth McLennan; Russell Thomson; Scott Carver; Samantha Fox; David Pemberton; Alexandre Kreiss; Adriana Baz Morelli; Anabel Silva; Martin J Pearse; Lynn M Corcoran; Katherine Belov; Carolyn J Hogg; Gregory M Woods; A Bruce Lyons
Journal:  Front Immunol       Date:  2018-02-19       Impact factor: 7.561

6.  Rabies of canid biotype in wild dog (Lycaon pictus) and spotted hyaena (Crocuta crocuta) in Madikwe Game Reserve, South Africa in 2014-2015: Diagnosis, possible origins and implications for control.

Authors:  Claude T Sabeta; Drienie Janse van Rensburg; Baby Phahladira; Debra Mohale; Robert F Harrison-White; Carlien Esterhuyzen; June H Williams
Journal:  J S Afr Vet Assoc       Date:  2018-04-26       Impact factor: 1.474

7.  Antibody response to Raboral VR-G® oral rabies vaccine in captive and free-ranging black-backed jackals (Canis mesomelas).

Authors:  Katja N Koeppel; Peter Geertsma; Brian F Kuhn; Ockert L Van Schalkwyk; Peter N Thompson
Journal:  Onderstepoort J Vet Res       Date:  2022-02-10       Impact factor: 1.792

8.  Accounting for animal movement improves vaccination strategies against wildlife disease in heterogeneous landscapes.

Authors:  Katherine M McClure; Guillaume Bastille-Rousseau; Amy J Davis; Carolyn A Stengel; Kathleen M Nelson; Richard B Chipman; George Wittemyer; Zaid Abdo; Amy T Gilbert; Kim M Pepin
Journal:  Ecol Appl       Date:  2022-03-31       Impact factor: 6.105

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.